{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Living Desk", "lead_paragraph": "MOST scientists who study coffee's health effects sound like fickle lovers. One week they love it. The next week they hate it. But they always agree on what it does in the brain. And now they are figuring out how it works. Caffeine is the most widely used psychoactive substance on earth, said Dr. Solomon Snyder, director of the neurosciences department at Johns Hopkins University in Baltimore. People love caffeine, he said, because it elevates their mood, decreases fatigue, enables them to work harder and helps them think more clearly. Researchers have even found that caffeine improves the racing performance of cross-country skiers at high altitudes.", "headline": {"main": "The Secrets of Caffeine, America's Favorite Drug"}, "abstract": null, "print_page": "1", "word_count": 1319, "_id": "4fd1a4c18eb7c8105d6bd37a", "snippet": "MOST scientists who study coffee's health effects sound like fickle lovers. One week they love it. The next week they hate it. But they always agree on what it does in the brain. And now they are figuring out how it works.    Caffeine is the most...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/08/07/garden/the-secrets-of-caffeine-america-s-favorite-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SNYDER, SOLOMON"}, {"name": "organizations", "value": "JOHNS HOPKINS UNIVERSITY"}, {"name": "subject", "value": "CAFFEINE"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "COFFEE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sandra", "lastname": "BLAKESLEE"}], "original": "By SANDRA BLAKESLEE"}, "document_type": "article", "pub_date": "1991-08-07T00:00:00Z", "section_name": "Home and Garden"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "EVIDENCE is mounting that doctors treat women with heart disease less aggressively than they treat men, but experts say many more studies in men and women will be needed to determine whether the women are getting too little treatment, men too much, or both just the right amount. Reports in a number of medical journals have led to charges of sexism in medicine, both in treatment and in the studies from which treatments are designed. Too often, critics say, doctors rely on findings in men in caring for women.", "headline": {"main": "Men, Women and Heart Disease: More Than a Question of Sexism", "kicker": "THE DOCTOR'S WORLD"}, "abstract": null, "print_page": "1", "word_count": 2071, "_id": "4fd1d2058eb7c8105d70d35d", "snippet": "EVIDENCE is mounting that doctors treat women with heart disease less aggressively than they treat men, but experts say many more studies in men and women will be needed to determine whether the women are getting too little treatment, men too much,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/08/06/science/the-doctor-s-world-men-women-and-heart-disease-more-than-a-question-of-sexism.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEART"}, {"name": "subject", "value": "MEN"}, {"name": "subject", "value": "DISCRIMINATION"}, {"name": "subject", "value": "WOMEN"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN, M.D"}, "document_type": "article", "pub_date": "1991-08-06T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "Selegiline is the generic name of a relatively new medication -- brand name Eldepryl -- for Parkinson's disease. Stelazine is the brand name of an older drug for other problems, and it can worsen parkinsonism. The two words aren't hard to confuse, especially in the prescription scrawl they teach at med school. According to a letter in The New England Journal of Medicine, that's what happened to two Parkinson's patients for whom selegiline was prescribed. Different pharmacists mistakenly gave both of them Stelazine, with bad effect in both cases.", "headline": {"main": "Topics of The Times; Perilous Prescription"}, "abstract": null, "print_page": "20", "word_count": 143, "_id": "4fd1b0288eb7c8105d6d0dba", "snippet": "Selegiline is the generic name of a relatively new medication -- brand name Eldepryl -- for Parkinson's disease. Stelazine is the brand name of an older drug for other problems, and it can worsen parkinsonism. The two words aren't hard to confuse,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1991/08/01/opinion/topics-of-the-times-perilous-prescription.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "TOPICS (TIMES COLUMN)"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PARKINSON'S DISEASE"}, {"name": "subject", "value": "HANDWRITING"}], "byline": null, "document_type": "article", "pub_date": "1991-08-01T00:00:00Z", "section_name": "Health; Opinion"}], "meta": {"hits": 3, "offset": 0, "time": 190}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}